Medexprim’s Post

Revolutionizing IHC Assays: Unlock Precision with Cellular Calibrators 🔬 Attention translational researchers and pathologists! 📣 Are you struggling with inconsistent IHC assay results and floating cutpoint errors? It's time to embrace a groundbreaking solution. 💡 Join Dr. Steven Bogen, CEO of Boston Cell Standards, in an eye-opening webinar as he unveils the power of cellular calibrators – the key to transforming IHC companion diagnostic testing. 🗝️ Discover how these innovative calibrators, funded by the National Cancer Institute, enable: ✅ Optimal separation of patient treatment groups ✅ Locking in expression level cutpoints ✅ Standardization across instruments and kit lots Don't miss this opportunity to learn from an expert and elevate your IHC assays to new heights. 🚀 Register now and unlock the potential of precision medicine! 🎯 #IHCAssays #CellularCalibrators #PrecisionMedicine #TranslationalResearch #Pathology Register here: https://lnkd.in/eeRv78mA

🌟 𝐄𝐥𝐮𝐜𝐢𝐝𝐚𝐭𝐚 𝐚𝐭 AACR #SanDiego 🌟 Elucidata has stayed at the forefront of #cancerresearch by helping translational R&D teams access quality data to work with. We understand the lack of analysis-ready data, the struggle to keep up with deluge of data from assays and ongoing clinical trials, and the immediate need for a solution. Catch our co-founder Abhishek Jha at the annual American Association for Cancer Research from April 5th to 10th to discuss potential solutions for #translationalmedicine - use Elucidata’s suite of solutions to facilitate biomarker discovery, inform trial design, or develop personalized treatment strategies with analysis-ready precision health data. Streamline the transition from targets to clinical development, and accelerate time to analysis. Email us at info@elucidata.io to DM us here to book a meeting with us! #DataHarmonization  #AACR24 #techbio

SOPHiA GENETICS is visualizing victory over cancer by leveraging #AI to unlock insights from NGS and multimodal data! Join us at #LabJAM to explore the crucial need to deploy powerful analytical tools that accurately identify key biomarkers from disparate constitutional and somatic oncology datasets. We will also discuss how consolidating #multimodal data into a single portal to stratify patient sets and predict therapeutic responses will be instrumental in delivering precision medicine. Amy Prater, Ph.D. Jeff Gaudet John Carey, MBA American Society for Clinical Laboratory Science #NGS #LabJAM24

𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗔𝗜: 𝗔 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗡𝗼𝗿𝗱𝗶𝗰 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 🎉 Exciting News! Our postdoctoral partnership with AstraZeneca is officially underway. This collaboration, involving Karolinska Institutet and Oslo University Hospital, is set to improve lung and breast cancer care through AI-driven precision diagnostics. 🌟 We’re thrilled to announce that Francisco J. Peña, PhD has been selected and started as the KI-postdoc from an impressive global pool of over 100+ candidates across KI and OUS. His project focuses on developing AI-based tools for precision medicine in cancer, utilizing existing diagnostic and clinical data to enhance patient outcomes. 🔜 From the same pool of talents, we eagerly awaiting the Oslo University Hospital announcement of their candidate, so that our projects can learn from each other and continuously improve. Stay tuned as we share our journey and breakthroughs in this exciting field! 💡 This partnership is a groundbreaking example of public-private cooperation across the Nordic region, designed to spur innovation and empower early career scientists. It’s all about transforming research into real-world clinical applications, directly benefiting patient care.   #CancerCareInnovation #PrecisionMedicine #AIinHealthcare #InnovationInHealthcare #NordicCollaboration #ResearchImpact #cancercare #partnership #AI #deeplearning #digitalpathology #computationalpathology #ki

In our labs, pretrained AI models leverage more than 1 million endpoints from in vitro, in vivo and patient therapy response data, to identify potential opportunities for drug repurposing for further study and validation. Learn more about what success with predictive AI can look like for cancer drug discovery and development at the upcoming PMWC - Precision Medicine World Conference. Book a meeting with Michael Boice, PhD, now: https://hubs.la/Q02f27Hb0. #ArtificialIntelligence #CancerResearch #AI #DrugDiscovery #DrugDevelopment #PrecisionOncology #PrecisionMedicine

Just completed a thought-provoking session of manuscript review. 📄✍️ Today's subject: a cutting-edge study intertwining the complex threads of multi-omics to distinguish between normal and tumor liver cells. The potential here is enormous, with implications that could ripple through the future of cancer diagnostics. Key takeaways? Integration of genomic data sets is not just innovative; it's transformative. 🧬💡 The authors are on the cusp of a breakthrough, but precision is key. I've suggested a resubmit with major corrections to refine their approach, ensuring their findings can be as impactful as their vision. Stay tuned for updates on this fascinating intersection of bioinformatics and oncology. The blend of data normalization, regression models, and k-means clustering could be the beacon leading us to earlier and more accurate cancer detection methods. For my peers in #Bioinformatics and #CancerResearch, what are your thoughts on multi-omics integration in diagnostics? #ScienceReview #ResearchInnovation

Enable Medicine Houston seminar reminder: Catch the session live at the James P. Allison Institute at MD Anderson Cancer Center tomorrow, May 14, starting from 11am CT! Pre-registration in the comments below. Hosted by keynote speaker Alexandro Trevino, PhD, from Enable Medicine, learn how you can make the most of your multimodal #biologicaldata to power the next generation of life-saving diagnostics and therapeutics. 1. Uncover the cutting-edge computational annotation methods and analysis capabilities developed by #machinelearning leaders at Enable Medicine. 2. Explore a comprehensive data-to-insights workflow, including search, mapping, and deep #computationalanalysis, powered by AI on the Enable Medicine platform. 3. Activate your structured, multimodal data to inform critical clinical and #drugdiscovery decisions, from #patientstratification to #indicationselection.

At J&J, one of my biggest motivators are the people within the wider healthcare community who share our tireless dedication and determination to bring transformative medicines to patients. An article published in The Pathologist from Ales Ryska, Chair, Department of Pathology, Charles University Medical Faculty, Hradec Králové, Czech Republic, shares key insights on how we can collaboratively make targeted treatments a reality for more cancer patients. Precision medicine holds promise in revolutionising the care landscape, and we must work collectively to make sure that all people living with cancer have access to biomarker testing and treatments that aim to target their unique disease characteristics. Have a read here: https://bit.ly/3XFXbII #PrecisionMedicine #BiomarkerTesting #Oncology

Learn about how AI is being developed to help create personalized cancer screening strategies with the AI4C Lecture Series!

👩💻 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐚𝐧 𝐄𝐧𝐝-𝐭𝐨-𝐞𝐧𝐝 𝐒𝐢𝐧𝐠𝐥𝐞-𝐜𝐞𝐥𝐥 𝐈𝐧𝐟𝐫𝐚 𝐟𝐨𝐫 4𝐱 𝐅𝐚𝐬𝐭𝐞𝐫 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 💡 📈 Some of the biggest initiatives today in BioPharma R&D are around building an AI-ready corpus of #singlecell data and robust infrastructures for insight generation. The Human Cell Atlas by the Chan Zuckerberg Initiative, National Cancer Institute (NCI)'s Human Tumor Atlas Network and Broad Institute of MIT and Harvard's Single Cell Portal are examples of initiatives building a large corpus of single-cell data. We believe the path forward has 2 key elements - 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐦𝐨𝐝𝐞𝐥 𝐚𝐫𝐜𝐡𝐢𝐭𝐞𝐜𝐭𝐮𝐫𝐞𝐬 𝐚𝐧𝐝 𝐥𝐚𝐫𝐠𝐞𝐫 𝐝𝐚𝐭𝐚 𝐜𝐨𝐫𝐩𝐮𝐬. 🔬 Learn about how Elucidata helped a leading Boston-based biotech company leverage single-cell RNA sequencing and machine learning to develop #precisiontherapies for complex inflammatory diseases. In this case study we shed light on the secret sauce to building an end-to-end single-cell infrastructure for generating biological insights! https://lnkd.in/gMv-y2t6